Naprosyn, Anaprox, Anaprox DS Articles
Medinox' NSAID prodrug enters clinic
10 June 2002
Revenue-free year for France's NicOx
4 March 2002
NicOx looking to acquire small drugs firm, says WSJ
4 February 2002
Update: Pharmacia gets US approval for Celebrex follow-up Bextra
20 November 2001
Merck's Arcoxia outdoes naproxen in RA trial
14 November 2001
Datamonitor expresses views on Celebrex vs Vioxx; Novartis ADHD drug
24 September 2001
Pozen to file requested data on MT 100 in 2002
20 September 2001
Canada accuses GSK, Roche of tax dodging
10 July 2001
Celebrex' efficacy and safety; new data
21 June 2001
Merckle unveils Phase II data on coxib rival
21 June 2001
Pozen completes Ph III program for MT 100
21 February 2001
Update - Celebrex and Vioxx panel review on COX-2 inhibitors
15 February 2001
Pozen rocked by delay to migraine drug
30 January 2001
AstraZeneca starts Pha II trials of NO-NSAID
25 January 2001
ICN buys rights to NSAIDs from Roche
9 January 2001
Correction: Merck's Vioxx
4 January 2001
Merck to seek Vioxx OK for rheumatoid
24 November 2000
Spanish drugmakers adapt to advent of generics regime
15 September 2000
Pfizer/Pharmacia's Celebrex tops leading NSAIDs in GI safety study
15 September 2000
Norwegian OTC sales "grew 2% in 1998"
10 February 2000
Healthy full-year results for many US pharmaceutical companies
27 January 2000
Merck & Co goes once-weekly with osteoporosis drug Fosamax
24 November 1999
Hefty increase in 3rd qtr revenues at Elan
26 October 1999
Merck's osteoarthritis drug in menstrual pain
21 October 1999
First launch of Merck's Vioxx in Mexico
29 March 1999
New Evidence Supports Vioxx GI Safety
15 December 1998
US Insurers Ponder COX-2 Inhibitors
23 November 1998
Pivotal Studies Of Celebrex Unveiled At ACR
19 November 1998
Pharmachemie Pushes Teva's Sales Up In Third Quarter
10 November 1998
Elan Regains Naprelan And Verelan Rights
24 September 1998
Andrx Submits ANDA For Bioequivalent Drugs
23 September 1998
Priority FDA Review For Searle's Celebra
25 August 1998
SkyePharma Files ANDA For Naproxen
30 July 1998
American Home Pharma Sales Up 7% For 2nd Qtr
22 July 1998
First Half Sales At Roche Leap 41%, Boosted By BM
13 July 1998
US Quarterly Financial Results Round-Up
23 April 1998
Efficacy Shown With Merck's Vioxx
21 April 1998
Novartis Rapped Over Doan Advertising
20 March 1998
Strong Growth At Elan Corp, Net Income Up 51%
9 February 1998
Strong Growth For US Drug Firms In 1997
28 January 1998
India Cuts Prices Of 72 Formulations
15 December 1997
First Ph III Data With Searle's Celecoxib
20 November 1997
FDA Warning On OTC Analgesics
20 November 1997
US Seniors Surveyed On Pain Relief
3 July 1997
Mimetix Starts Phase I Nanox Trials
5 May 1997
Sales Slip At American Home Products
5 May 1997
FDA Approves Pharmaceutical Formulations' Naproxen
24 April 1997
Elan Corp Takes One-Time Charge At Nine Months
10 February 1997
Euro OTC Pain Relief Market Led By Intl Brands
27 January 1997
Roche's 1996 Sales Ahead Of Expectations
27 January 1997
Elan Corp's 2nd Quarter Reflects Athena Acquistion
4 November 1996
Searle Reports Progress With COX-2 Inhibitor
21 October 1996
Frenetic 12 Months For SkyePharma
14 October 1996
World OTC Market Growth Disappoints In 1995
14 October 1996
Roche And Bayer Link Up In US OTC Joint Venture
23 September 1996
UK Launch Of Boeh Ingelheim's NSAID Meloxicam
9 September 1996
Consumers And Self-Medication: World Studies
9 September 1996
Single-Digit Profits Growth For B-MS And W-L
5 August 1996
Net profits Up Over 50% At Elan Corp
5 August 1996
Patent Expiries Set To Drive Generics Boom
22 July 1996
Roche Moves To Increase OTC Stake In USA
8 July 1996
Wyeth-Ayerst Launches Naprelan
10 June 1996
FDA Panel Rejects Pfizer's Tenidap Application
13 May 1996
Strong Year-End For Elan Corporation
13 May 1996
Sales In Line With Expectations At Roche In '96 1st Qtr
22 April 1996
Rheumatoid Arthritis And Disease Management
22 April 1996
Earnings Growth In Excess of 25% At Elan?
15 April 1996
Tylenol/Advil Ad Row "A US Investment Non-Event"
1 April 1996
B-MS Introduces New NSAID In UK
25 March 1996
B-MS Introduces New NSAID In UK
25 March 1996
Brussels Probes Roche Austrian "Subsidy"
4 March 1996
Chiroscience Deal With Conti
5 February 1996
Elan's Naprelan: news
22 January 1996
Elan Corporation Sees Net Profits Rise 28%
22 January 1996
Elan gets new Naprelan approval
15 January 1996
Bayer/Whitehall Set To Launch OTC Ketoprofen In USA
23 October 1995
Generics: A Passage Through Time
4 September 1995
Procter & Gamble To Expand Drugs Business
14 August 1995
Elan/Wyeth-Ayerst agreement to market Naprelan
31 July 1995
US Sales of Generic Drugs Up 29% In 1994, Says IMS
17 July 1995
India To Reduce Bulk Drug Prices
3 July 1995
Rugby Group gets approval for gemibrozil
19 June 1995
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
